Vir Biotechnology, Inc. , a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases.
Vir Biotechnology stock last closed at $7.96, down 3.52% from the previous day, and has decreased 68.16% in one year. It has underperformed other stocks in the Biotechnology industry by 0.42 percentage points. Vir Biotechnology stock is currently +3.11% from its 52-week low of $7.72, and -71.03% from its 52-week high of $27.48.
At the moment, there are 135.03M VIR shares outstanding. The market value of VIR is $1.07B. In the last 24 hours, 868,172 VIR shares were traded.
How to Buy Vir Biotechnology Stock
Wondering how to invest in Vir Biotechnology stock? Here's how.
Choose where to buy Vir Biotechnology stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you decide where to buy Vir Biotechnology stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Fund your brokerage account: Select your method of payment and add your info.
Analyze Vir Biotechnology stock: The Vir Biotechnology ticker symbol is VIR. Is Vir Biotechnology stock a good investment? Should you buy shares of VIR? How do VIR's underlying business fundamentals look? Do top analysts think Vir Biotechnology is a good buy? Why has VIR's stock price moved recently? (Hint: Our stock research website can help you understand if VIR is a good stock to buy).
Execute your VIR buy order: Decide if you will purchase VIR shares at the current market price or use a limit order to buy VIR shares at a particular price.
Get the latest news on your VIR position: Create a watchlist to important updates regarding your position in Vir Biotechnology stock.
Step 1: Choose where to buy Vir Biotechnology stock
You need an online brokerage account to access the NASDAQ market and buy VIR stock.
A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. Here's why:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global financial markets: From Technology to Energy, New York to Tokyo — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've selected the right brokerage, it's time to fill out some personal information so you are able to buy VIR stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Vir Biotechnology stock
After you have chosen the best place to buy Vir Biotechnology stock, it's critical to analyze their stock prior to investing, so you truly comprehend the risk as well as the upside.
Vir Biotechnology Metrics
VIR Price
$7.96
1w %
-13.85%
1y %
-68.16%
5y %
N/A
P/E
-1.73x
P/B
0.68x
P/S
12.38x
PEG
N/A
Revenue
$86.18M
Earnings
-$615.06M
Fore. Rev. Growth
-5.58%
Fore. Earn. Growth
N/A
Market Cap
$1.07B
Next Earnings
May 2, 2024
Next Dividend
N/A
Vir Biotechnology Zen Score
WallStreetZen was designed to help average investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on VIR's stock page.
How is VIR stock valued?
You can use many financial metrics, analyses, models, and charts to gauge VIR's true value.
Using relative valuations metrics:
VIR could be undervalued based on its P/B ratio of 0.68x, relative to Biotechnology industry P/B ratio of 5.76x
You can access additional valuation analysis on VIR's stock here.
A look at VIR Cashflows and Balance Sheet
Pros:
VIR has cash burn of 800358000. It has enough cash and short-term investments to cover this for at least one year.
Total VIR debt is lower than 5 years ago, relative to shareholder equity.
There are more short-term assets than short-term liabilities on the VIR balance sheet.
There are more short-term assets than long-term liabilities on the VIR balance sheet.
VIR has a low debt to equity ratio of 0.21.
Cons:
VIR has $1.54B in cash and short term investments. This is not enough to cover its annual cash burn of $800.36M.
VIR profit margin has gone down from 31.9% to -713.7% in the past year.
Is Vir Biotechnology stock a Buy, Hold, or Sell, according to analysts?
Out of 3 Equities analysts who track VIR, the consensus analyst rating on Vir Biotechnology is a Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
Last year, VIR revenue was $86.18M. In the last five year, VIR's revenue has increased by 51.87% per year. This was faster than the Biotechnology industry average of 28.98%.
No, Vir Biotechnology doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your VIR buy order
There are two primary options:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are usually the best for newer investors.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at an exact dollar amount limit, use a limit order.
Press the Open button and your broker will execute the order.
If you require additional help with buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Vir Biotechnology share?
As of Apr 18, 2024, it costs $7.96 to buy one share of Vir Biotechnology stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.377 shares of VIR.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.